Table 1. Patient characteristics and tumor evaluation.
Patient | Sex | Age | Pathology of Biopsy | Comments |
1 | F | 77 | NSCLC, MD-PD, favor adenocarcinoma | |
2 | F | 66 | Necrosis, no viable neoplasm identified | |
3 | M | 49 | Not obtained | Prior NSCLC diagnosis, fiducial placed for SBRT |
4 | M | 73 | Small cell carcinoma | |
5 | F | 73 | Not obtained | Prior NSCLC diagnosis, fiducial placed for SBRT |
6 | F | 68 | Not obtained | Prior adenocarcinoma diagnosis, fiducial placed for SBRT |
7 | F | 52 | Alveolar tissue and cartilage fragments | Prior history of C/L lung adenocarcinoma |
8 | M | 82 | Lung parenchyma with no evidence of malignancy | Core biopsy later showed squamous cell carcinoma |
Median: | 70.5 | |||
Range: | 49–82 |
M-male; F-female; NSCLC-non small cell lung cancer; MD-PD-moderately differentiated to poorly differentiated; SBRT-stereotactic body radiotherapy.